10x Genomics, Inc. financial data

Symbol
TXG on Nasdaq
Location
Pleasanton, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 511% % 2.4%
Quick Ratio 60% % -18%
Debt-to-equity 29% % -1.7%
Return On Equity -10% % 59%
Return On Assets -8% % 59%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 122,291,837 shares 2.7%
Entity Public Float $1,800,000,000 USD -68%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 125,502,291 shares 4%
Weighted Average Number of Shares Outstanding, Diluted 125,502,291 shares 4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $641,814,000 USD 1.9%
Cost of Revenue $200,023,000 USD -4.9%
Operating Income (Loss) $91,283,000 USD 54%
Nonoperating Income (Expense) $18,189,000 USD -24%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $73,094,000 USD 58%
Income Tax Expense (Benefit) $3,226,000 USD -51%
Net Income (Loss) Attributable to Parent $76,320,000 USD 58%
Earnings Per Share, Basic 0 USD/shares 60%
Earnings Per Share, Diluted 0 USD/shares 60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $344,067,000 USD -4.2%
Accounts Receivable, after Allowance for Credit Loss, Current $43,779,000 USD -48%
Inventory, Net $61,956,000 USD -34%
Assets, Current $659,827,000 USD 11%
Property, Plant and Equipment, Net $232,534,000 USD -10%
Operating Lease, Right-of-Use Asset $63,650,000 USD 6.8%
Intangible Assets, Net (Excluding Goodwill) $64,759,000 USD 301%
Goodwill $4,511,000 USD 0%
Other Assets, Noncurrent $1,879,000 USD -62%
Assets $1,027,361,000 USD 9.6%
Accounts Payable, Current $18,069,000 USD -31%
Employee-related Liabilities, Current $37,084,000 USD 23%
Contract with Customer, Liability, Current $22,139,000 USD 25%
Liabilities, Current $147,324,000 USD 22%
Contract with Customer, Liability, Noncurrent $10,871,000 USD -12%
Operating Lease, Liability, Noncurrent $76,442,000 USD -0.02%
Other Liabilities, Noncurrent $6,394,000 USD 29%
Liabilities $242,241,000 USD 13%
Accumulated Other Comprehensive Income (Loss), Net of Tax $138,000 USD 331%
Retained Earnings (Accumulated Deficit) $1,494,339,000 USD -5.4%
Stockholders' Equity Attributable to Parent $785,120,000 USD 8.6%
Liabilities and Equity $1,027,361,000 USD 9.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $34,351,000 USD
Net Cash Provided by (Used in) Financing Activities $422,000 USD -74%
Net Cash Provided by (Used in) Investing Activities $1,893,000 USD -118%
Common Stock, Shares Authorized 1,100,000,000 shares 0%
Common Stock, Shares, Issued 122,291,837 shares 2.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $32,994,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $432,709,000 USD 8.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $479,452,000 USD 8.2%
Deferred Tax Assets, Gross $496,171,000 USD 7.8%
Operating Lease, Liability $86,985,000 USD 1.3%
Payments to Acquire Property, Plant, and Equipment $1,893,000 USD -35%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $76,214,000 USD 58%
Lessee, Operating Lease, Liability, to be Paid $106,866,000 USD 1%
Property, Plant and Equipment, Gross $378,343,000 USD -1.3%
Operating Lease, Liability, Current $10,543,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $16,799,000 USD 8.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $16,612,000 USD 11%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $19,881,000 USD -0.04%
Lessee, Operating Lease, Liability, to be Paid, Year Three $16,382,000 USD 4.4%
Deferred Tax Assets, Operating Loss Carryforwards $161,681,000 USD -3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Unrecognized Tax Benefits $50,022,000 USD 9.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,788,000 USD -6.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $8,022,000 USD -13%
Deferred Tax Assets, Net of Valuation Allowance $16,719,000 USD -3.8%
Share-based Payment Arrangement, Expense $115,803,000 USD -21%
Interest Expense $15,000 USD -96%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%